AIMEDIC 로고 이미지
모바일 메뉴 닫기
About AIMEDIC
모바일 서브 메뉴 닫기
Our Story
Our History
Products
모바일 서브 메뉴 닫기
HeartMedi+
AutoSeg
AngioFFR
CardioLucid
Publications
모바일 서브 메뉴 닫기
News
모바일 서브 메뉴 닫기
Contact us
모바일 서브 메뉴 닫기
Back to Publications

AIMEDIC Publications

Minimal systems analysis of mitochondria-dependent apoptosis induced by cisplatin

Category
Pub
Date
2016-07-01
Source
The Korean journal of physiology & pharmacology: official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Recently, it was reported that the role of mitochondria-reactive oxygen species (ROS) generating pathway in cisplatin-induced apoptosis is remarkable. Since a variety of molecules are involved in the pathway, a comprehensive approach to delineate the biological interactions of the molecules is required. However, quantitative modeling of the mitochondria-ROS generating pathway based on experiment and systemic analysis using the model have not been attempted so far. Thus, we conducted experiments to measure the concentration changes of critical molecules associated with mitochondrial apoptosis in both human mesothelioma H2052 and their ρ0 cells lacking mitochondrial DNA (mtDNA). Based on the experiments, a novel mathematical model that can represent the essential dynamics of the mitochondrial apoptotic pathway induced by cisplatin was developed. The kinetic parameter values of the mathematical model were estimated from the experimental data. Then, we have investigated the dynamical properties of this model and predicted the apoptosis levels for various concentrations of cisplatin beyond the range of experiments. From parametric perturbation analysis, we further found that apoptosis will reach its saturation level beyond a certain critical cisplatin concentration.

Content update: API publication dates are used first. Review the abstract, source link, product intended use, and limitations together.

맨 위로 이동